Page 3 - Micro Labs News Today

OTC medicines generally do not require a doctors prescription and include products such as immunity-boosting vitamins, skin ointments, lozenges, and pain relief gels. This segment has been growing at a robust rate of 10-15%, making it one of the fastest-growing segments in the pharmaceutical market. Dolo, known for its pain and fever relief properties, achieved significant recognition during the pandemic, resulting in a 30% increase in sales to approximately Rs 350 crore last year.

Bengaluru-based pharmaceutical company Micro Labs is expanding into the over-the-counter (OTC) segment with wellness products, following the success o

Seven drugs have been listed as in shortage since Oct. 9, according to the FDA and ASHP. Learn more about these drugs, including the reasons for the shortage an

(This story has not been edited by THE WEEK and is auto-generated from a PTI

Global Dorzolamide Hydrochloride Market Analysis (2019 - 2030)

Get latest articles and stories on Business at LatestLY. New Delhi [India], August 16: Micro Labs Ltd, a renowned pharmaceutical company, proudly announced the launch of Trisopt, the world's first fixed-dose combination of Brimonidine, Timolol, and Brinzolamide ophthalmic suspension for glaucoma management. Trisopt is an indigenous development from Micro Labs, manufactured in their state-of-the-art facility located in Sikkim. Business News | Micro Labs Ltd Introduces Trisopt: World&#03...

The top 300 pharmaceutical brands in the country will now bear a quick response (QR) code on their packaging to rein in spurious drugs and ensure better traceability.

In a conflict-affected region, many people struggle with insomnia and seek solace in sleeping pills. The long-term dependence on these medications has serious consequences for mental and physical health. The pandemic-induced stress has also contributed to rising insomnia cases. Despite regulations, the easy availability of these pills without prescriptions adds to the problem. Experts emphasise the importance of alternative treatments like cognitive-behavioral therapy and lifestyle modifications...

Pharma companies in India are struggling to enforce compounds that are covered by both genus and subsequent species patents. While the latest case involved a series of injunctions being vacated, the patent community is still unsatisfied by the lack of concrete judgments on this issue.

Dilip Surana News, Chairman and MD of Micro Labs, Surana Family Net Worth, Businesses, residence and more, Business News, Times Now